Core Viewpoint - The implementation plan for the digital transformation of the pharmaceutical industry from 2025 to 2030 aims to enhance high-quality development and improve industry competitiveness and innovation capabilities through digital transformation [2] Group 1: Company Initiatives - The company is actively conducting research to anticipate industry technology development trends and regulatory requirements [2] - The company is focusing on strengthening the recruitment of R&D talent and enhancing R&D capabilities [2] - The company aims to continuously improve the intelligence level of its products to provide comprehensive intelligent manufacturing solutions for pharmaceutical enterprises [2]

证券日报网讯 1月15日，东富龙在互动平台回答投资者提问时表示，公司积极开展研究工作，前瞻行业 技术发展趋势及法规要求，不断提升产品的智能化水平，为制药企业提供智能制造整体解决方案。 （文章来源：证券日报） ...